Phase II Study of Treosulfan/Fludarabine/ Low Dose Total Body Irradiation As a Preparative Regimen for Children with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Hematopoietic Cell Transplantation
Eneida R. Nemecek(Oregon Health & Science University), Colleen Delaney(Seattle Children's Hospital), Deidre M. Kiefer(National Marrow Donor Program), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), John E. Levine(Icahn School of Medicine at Mount Sinai), Rabi Hanna(Cleveland Clinic), Paul R. Haut(Indiana University Health), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Wing Leung(KK Women's and Children's Hospital), Alexia Adams(National Marrow Donor Program), Jennifer Le‐Rademacher(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph H. Chewning(Kettering University), Jignesh Dalal(Rainbow Babies & Children's Hospital), Gregory A. Yanik(University of Michigan), Julie‐An Talano(Dana-Farber Cancer Institute), Neena Kapoor(University of Southern California), Aleksandra Petrović(Seattle Children's Hospital), David Delgado(Indiana University Hospital), Roberta H. Adams(Mayo Clinic in Arizona), Michael A. Pulsipher(Primary Children's Hospital), Stacy Epstein(Carolinas Medical Center), Michael R. Verneris(NHS Blood and Transplant)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|648